Esperion Therapeutics Inc (ESPR)
1.975
-0.02
(-0.75%)
USD |
NASDAQ |
Apr 30, 16:00
1.99
+0.02
(+0.76%)
After-Hours: 20:00
Esperion Therapeutics Price: 1.975 for April 30, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 29, 2024 | 1.93 | 2.02 | 1.88 | 1.99 | 3.853M |
Apr 26, 2024 | 2.01 | 2.01 | 1.88 | 1.90 | 4.199M |
Apr 25, 2024 | 2.10 | 2.10 | 1.95 | 1.99 | 5.147M |
Apr 24, 2024 | 2.11 | 2.16 | 2.06 | 2.13 | 5.684M |
Apr 23, 2024 | 1.93 | 2.13 | 1.92 | 2.09 | 4.947M |
Apr 22, 2024 | 1.97 | 1.97 | 1.84 | 1.91 | 4.792M |
Apr 19, 2024 | 1.78 | 1.965 | 1.71 | 1.95 | 7.350M |
Apr 18, 2024 | 1.86 | 2.03 | 1.81 | 1.87 | 6.039M |
Apr 17, 2024 | 1.91 | 1.96 | 1.81 | 1.84 | 3.719M |
Apr 16, 2024 | 1.91 | 1.990 | 1.835 | 1.91 | 6.181M |
Apr 15, 2024 | 2.12 | 2.13 | 1.93 | 1.935 | 6.823M |
Apr 12, 2024 | 2.33 | 2.42 | 2.04 | 2.14 | 7.547M |
Apr 11, 2024 | 2.47 | 2.54 | 2.25 | 2.31 | 8.815M |
Apr 10, 2024 | 2.72 | 2.746 | 2.45 | 2.52 | 8.988M |
Apr 09, 2024 | 3.00 | 3.17 | 2.76 | 2.79 | 5.752M |
Apr 08, 2024 | 3.40 | 3.40 | 2.90 | 3.03 | 7.893M |
Apr 05, 2024 | 3.17 | 3.40 | 3.02 | 3.24 | 10.48M |
Apr 04, 2024 | 3.30 | 3.40 | 3.03 | 3.11 | 11.29M |
Apr 03, 2024 | 2.95 | 3.33 | 2.90 | 3.12 | 21.22M |
Apr 02, 2024 | 2.80 | 3.005 | 2.690 | 2.88 | 6.301M |
Apr 01, 2024 | 2.70 | 2.875 | 2.63 | 2.79 | 7.384M |
Mar 28, 2024 | 2.64 | 2.80 | 2.54 | 2.68 | 8.248M |
Mar 27, 2024 | 2.78 | 2.80 | 2.52 | 2.62 | 11.97M |
Mar 26, 2024 | 2.60 | 2.96 | 2.55 | 2.70 | 14.76M |
Mar 25, 2024 | 2.73 | 2.76 | 2.31 | 2.62 | 27.46M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.7304
Minimum
Oct 26 2023
73.84
Maximum
Feb 13 2020
19.77
Average
9.55
Median
Oct 19 2021
Price Benchmarks
United Therapeutics Corp | 235.13 |
Dynavax Technologies Corp | 11.36 |
Heron Therapeutics Inc | 2.31 |
Aldeyra Therapeutics Inc | 3.935 |
Deciphera Pharmaceuticals Inc | 25.26 |
Price Related Metrics
PS Ratio | 1.749 |
Earnings Yield | -107.3% |
Market Cap | 365.48M |